Goldman Sachs infuses $230M into clinical trial software maker

Goldman Sachs has set its sight on health tech. 4G Clinical, a Wellesley-based developer of software to support clinical trials, has brought in $230 million from the New York wealth management giant, with the promise to expand into new geographies, get its products to market and grow its team by about one-third.